Mount Sinai Begins Pilot of Respiratory Disease Management Platform
The Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is conducting an investigational pilot study of a respiratory disease management platform, developed by Cohero Health, in pediatric asthma patients seen in two high volume pediatric clinics at the Mount Sinai Health System. Patients will use Cohero’s platform that employs connected devices and a game-based mobile app to increase and monitor adherence to asthma medication.
“Mount Sinai's work with CoheroHealth demonstrates its commitment to clinical innovation through technology and entrepreneurship,” said Daniel Seltzer, Director of the Center for Technology Innovation and Entrepreneurship (C-TIE) at Mount Sinai Health System; the Cohero Health team worked closely with C-TIE in developing its innovative platform and helping bring it to market.
Cohero’s platform consists of their HeroTracker™ sensor that attaches to a medication inhaler to track medication use and syncs wirelessly to Cohero’s AsthmaHero™ mobile application. The app tracks adherence over time, generates customized reminders and provides a game experience that offers patients in-app and monetary rewards for consistently taking their medication as prescribed. It can also provide parents and caregivers with real time updates of patient medication use as well as weekly and monthly summary reports. The system also incorporates a mobile spirometer to track clinically relevant lung function measures between office visits.
“Cohero is a result of my years of research in chronic respiratory care,” said Cohero co-founder Melissa Manice, PhD, a Post-Doctoral Fellow in the Department of Population Health Science and Policy at Mount Sinai. “Our platform was designed to address the hurdles to proper care and help reduce the overall cost of treating respiratory disease.”
"Adherence to controller medication is essential for the proper treatment of asthma. I’m looking forward to seeing how Cohero's technology of reminding and rewarding patients will improve adherence,” said Dr. Andrew Ting, Pediatric Pulmonologist at The Mount Sinai Hospital.
In addition, by collecting data on controller and rescue medication use, along with the resulting changes in pulmonary function, Cohero is able to conduct predictive analytics in novel ways. “At the patient-level, the platform enables identification of exacerbations and their causes before they occur. On a macro-level, it enables analysis of how patient populations use respiratory drugs, and the resulting effect on lung function,” said Cohero co-founder Daniel Weinstein.
Cohero’s technology supports EMR integration, which enables patient data to be transferred automatically and securely directly into a patient’s record. "Having ready access to adherence and spirometry data will give me a much clearer picture of what's happening with my patients, and will be helpful for our clinical decision making," said Dr. Ting.
The study will measure improvements in medication adherence and lung function of patients using Cohero’s platform as compared to a control group.
About CoheroHealth, LLC
CoheroHealth is a digital health company focused on bringing innovative technologies to improve respiratory care. The company uses connected devices and an interactive, game based, mobile application to track and improve medication adherence and lung function. The company is located in New York City, and is a participant in StartupHealth, Springboard, and GrandCentral Tech startup accelerator programs. Dr. Melissa Manice is a co-founder and equity-holder in CoheroHealth. Visit http://www.coherohealth.com or email info@coherohealth.com for more information.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
New Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation
Dec 21, 2023 View All Press Releases
